DNTH vs TER · rev $6.2M vs P/E 76, rev $2.82B
Dianthus Therapeutics Inc. (DNTH) versus Teradyne Inc (TER) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Teradyne Inc (TER) is a semiconductor equipment & materials company listed on NASDAQ.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
Latest reported TER revenue for 2024-12-31 was $2.82B. Net income was $542.4M. Revenue was up 5.4% from 2023-12-31 to 2024-12-31. TER currently screens at market cap $63.96B and trailing P/E 75.7.
DNTH currently screens at market cap $4.40B. TER currently screens at market cap $63.96B and trailing P/E 75.7.
Not investment advice. Open the DNTH and TER stock pages for the full models.
Not investment advice.